"GLP-1s like Ozempic: A Game-Changer in Obesity and Diabetes Management"
TL;DR Summary
Companies are grappling with whether to cover GLP-1s like Ozempic, which cost nearly $1,000 per month, for their employees. Up to 130 million Americans could qualify for the drug, but some are questioning whether dosing a third to half of the U.S. population is a good idea. While GLP-1s offer hope for weight loss without strict dieting or surgery, concerns remain about the high cost and potential long-term effects on public health and healthcare costs.
- Should employer health plans cover GLP-1s like Ozempic? - STAT STAT
- New Obesity Drugs Come With a Side Effect of Shaming Yahoo! Voices
- Drugs that melt away pounds still present more questions than answers, but Ozempic, Wegovy, and Mounjaro could be key tools in reducing the obesity epidemic The Philadelphia Inquirer
- Unveiling the game-changing diabetic drugs: Revolutionizing weight loss and diabetes management Kevin MD
- Analysis | What You Need to Know About Drugs Like Ozempic Being Used for Weight Loss The Washington Post
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
1 min
vs 1 min read
Condensed
60%
188 → 75 words
Want the full story? Read the original article
Read on STAT